Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Solaris Vaccines Logo
Solaris Vaccines Growth Score
27
CB Rank
144263
Heat Score
45
Solaris Vaccines is a biotechnology company that develops therapeutic vaccines for infectious diseases.
Founded
obfuscation
PrivateDebt Financing Fort Collins, Colorado, United States1-10 solarisvax.com
Biotechnology
Health Care
Life Science
Therapeutics
Overview

Solaris Vaccines
Total Funding
obfuscation
Growth Score
27
Heat Score
45

Total Funding
obfuscation
obfuscation
Debt Financing raised
obfuscation
Growth Score27
-30 pts
in past quarter
Heat Score 45
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Solaris Vaccines

CB Rank
144263
Solaris Vaccines is a biotechnology company that develops therapeutic vaccines for infectious diseases.
Founded
obfuscation
PrivateDebt Financing Fort Collins, Colorado, United States1-10 solarisvax.com
Biotechnology
Health Care
Life Science
Therapeutics

Funding Rounds

Debt Financing
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Solaris Vaccines, Inc.
Operating Status Active
Company Type For Profit
About the Company
Solaris Vaccines is a biotechnology company that develops therapeutic vaccines for infectious diseases. The Solaris SolaVAX method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria, and parasites.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

SolaVAX™ method
A vaccine development method using riboflavin and UV light to inactivate pathogens for creating vaccines against viruses, bacteria, and parasites.
SolaVAX™-CoV-2 investigational vaccine
An investigational vaccine for COVID-19 showing reduced viral load and improved lung health in animal models, developed using the SolaVAX™ method.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing
obfuscation
Debt Financing - Solaris Vaccines Logo
Debt Financing - Solaris Vaccines
1
obfuscation
— Debt Financing

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

94

IT Spend

$136.9KThis year, Solaris Vaccines is projected to spend $136.9K on IT, according to Aberdeen.

Active Website Tech Count

3Solaris Vaccines is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Solaris Vaccines's headquarters? Solaris Vaccines is located in Fort Collins, Colorado, United States.Who invested in Solaris Vaccines? Solaris Vaccines is funded by VIC Technology Venture Development.When was the last funding round for Solaris Vaccines? Solaris Vaccines closed its last funding round on
obfuscation
from a Debt Financing round.Who are Solaris Vaccines's competitors? Alternatives and possible competitors to Solaris Vaccines may include Valneva, GeoVax, and  Novavax.How much funding has Solaris Vaccines raised to date? Solaris Vaccines has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|